期刊文献+

化学计量学二阶校正法结合三维荧光光谱技术同时快速测定人血清样中西酞普兰、氟西汀和帕罗西汀含量 被引量:2

Simultaneous and Rapid Determination of Citalopram,Fluoxetine and Paroxetine Contents in Human Serum Samples Using Three -dimensional Fluorescence Technique Coupled with Chemometric Second order Calibration
在线阅读 下载PDF
导出
摘要 应用化学计量学二阶校正方法结合三维荧光光谱技术可以实现人血清样中西酞普兰、氟西汀和帕罗西汀含量的直接、快速同时测定。设定荧光激发波长范围为210~260 nm,发射波长为270~388 nm,测定不同样本的三维荧光光谱,构建三维响应数阵。当选取体系组分数为4时,采用PARAFAC方法得到的血清样中西酞普兰、氟西汀和帕罗西汀的加标回收率(95%置信区间)分别为95.9±3.22%、104.5±8.17%和96.4±5.15%,并采用品质因子和椭圆置信区间测试对结果进行了进一步验证。实验结果表明,该方法快速简便,解析结果可靠,无需样本预处理,能直接用于同时分析人血清中西酞普兰、氟西汀和帕罗西汀的含量。 A novel and effective approach was developed for the simultaneous determination of citalopram(CIT),fluoxetine(FLU) and paroxetine(PAR) in human plasma samples by the incorporation of excitationemission fluorescence(EEM) and second-order calibration method based on the parallel factor analysis(PARAFAC) algorithm.The scanning range of their excitation and emission wavelengths were set at 210~260 nm and 270~380 nm,respectively.The obtained 95% confidence interval of CIT,FLU and PAR in human serum samples by using PARAFAC method with an estimated component number of four were 95.9 ±3.22,104.5±8.17 and 96.4±5.15%,respectively.Moreover,the accuracy of the method was also evaluated through elliptical joint confidence region(EJCR) tests as well as the figures of merit.The experimental results demonstrated that the method has been satisfactorily applied to determination of CIT,FLU and PAR in human serum samples without previous separation procedure.
出处 《精细化工中间体》 CAS 2013年第1期63-68,共6页 Fine Chemical Intermediates
基金 国家自然基金资助项目(21175041)
关键词 三维荧光光谱 二阶校正 西酞普兰 氟西汀 帕罗西汀 three-dimensional fluorescence spectroscopy second-order calibration citalopram fluoxetine paroxetine
  • 相关文献

参考文献21

  • 1Mourilhe P,Stokes P E.Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression[J].Drug Safety,1998,18(1):57-82.
  • 2George M.Anderson.Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors(SSRIs)in humans and nonhuman primates:assessing bioeffect and mechanisms of action[J].Int J Devl Neuroscience,2004,22(5):397-404.
  • 3Ghoneima O M,Ibrahimb D A,El-Deebc I M,et al.A novel potential therapeutic avenue for autism:Design,synthesis and pharmacophore generation of SSRIs with dual action[J].Bioorg Med Chem Lett,2011,21(22):6714-6723.
  • 4Ellfolk M,Malm H.Risks associated with in utero and lactationexposure to selective serotonin reuptake inhibitors(SSRIs)[J].Reprod Toxicol,2010,30:249-260.
  • 5Fava M,Rush A J.Current status of augmentation and combination treatments for major depressive disorder:a literature review and a proposal for a novel approach to improve practice[J].Psychother Psychosom,2006,75:139-153.
  • 6Berzas J J,Alanón A,Lázaro J A.Cyclodextrin enhanced spectrofluorimetric determination of fluoxetine in pharmaceuticals and biological fluids[J].Talanta,2002,58:301-309.
  • 7Labat L,Deveaux M,Dallet P,et al.Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography[J].J Chromatogr B,2002,773:17-23.
  • 8Satana E,Ertas N,Ger N G.Determination of citalopram using flow injection-solid phase extraction with spectrofluorometric detection.chromatographia supplement[J].2007,66:75-79.
  • 9Walsh M,Belal F,El-Enany N,et al.Spectrofluorimetric determination of paroxetine hcl in pharmaceuticals via derivatization with4-chloro-7-nitrobenzo-2-oxa-1,3-diazole(NBD-Cl)[J].J Fluoresc,2011,21:105-112.
  • 10Wu H L,Nie J F,Yu Y J,et al.Multi-way chemometric methodologies and applications:A central summary of our research work[J].Anal Chim Acta,2009,650(1):131-142.

二级参考文献30

共引文献10

同被引文献41

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部